Search Results (18)

Unmanned aerial vehicles (UAVs) are emerging as powerful tools for transporting temperature-sensitive payloads, including medical supplies, biological samples, and research materials, to remote or hard-to-reach locations. Effective thermal management is essential for maintaining payload integrity, especially during extended flights or harsh environmental conditions. This review presents a comprehensive analysis of temperature control mechanisms for UAV payloads, covering both passive and active strategies. Passive systems, such as phase-change materials and high-performance insulation, provide energy-efficient solutions for short-duration flights. In contrast, active systems, including thermoelectric cooling modules and Joule heating elements, offer precise temperature regulation for more demanding applications. We examined case studies that highlight the integration of these technologies in real-world UAV applications, such as vaccine delivery, blood sample transport, and in-flight polymerase chain reaction diagnostics. Additionally, we discussed critical design considerations, including power efficiency, payload capacity, and the impact of thermal management on flight endurance. We then presented an outlook on emerging technologies, such as hybrid power systems and smart feedback control loops, which promise to enhance UAV-based thermal management. This work aimed to guide researchers and practitioners in advancing thermal control technologies, enabling reliable, efficient, and scalable solutions for temperature-sensitive deliveries using UAVs. Full article

We aim to implement a three-tiered healthcare supply chain model within the context of a portable blood hub during times of crisis to provide healthcare to the most vulnerable populations. Due to a lack of blood, the number of deaths related to this issue has significantly increased in recent years. A critical challenge for healthcare decision-makers is the efficient distribution of blood among different centers. This research proposes a new method to address this issue, simplifying future solutions to similar problems. As a result of our findings, we introduce a model that considers three tiers in healthcare blood supply: point one (blood collection centers), point two (blood hubs), and final destinations (hospitals and clinics) during disasters. For this study, we focused on six collection sites, five blood centers, and thirty-one medical facilities providing eight different blood types. Our model demonstrates that blood can be transported from collection sites to medical centers at a lower cost during crises. This approach requires considering the full three tiers of the healthcare supply chain rather than focusing solely on the supply chain level at blood hubs. Unlike previous studies, which focused only on individual levels of supply chain management, this study examined the entire value chain, from blood collection to delivery to the end recipient. Full article

Background: The blood supply chain (BSC) is crucial for providing safe and sufficient blood, but it faces numerous challenges and needs to be robust and resilient. This study provides a comprehensive model for managing and optimizing the BSC in real-world scenarios, including emergency and routine circumstances and with consideration of health equity concepts. Method: Classic time-series models are applied to predict future supply chain circumstances, addressing uncertainty in blood demand and the need for timely supply. A structured framework and medical preferences are prioritized to optimize distribution, minimize blood shortages, minimize wastage due to expiry, and maximize blood freshness. Genetic algorithms (GA) and particle swarm optimization (PSO) are used to solve mathematical models quickly and efficiently, ensuring reliable operation. Result: The model’s outcomes can effectively meet the daily needs of the BSC and assist decision-makers managing blood inventory and distribution, improving robustness and resilience. Conclusions: Utilizing weights allows for the effective management of each objective function to convert the model into a single-objective mixed-integer linear programming (SO-MILP) based on unique conditions, enabling the system to self-adjust for optimal performance, boosting the sustainability of the blood supply chain, and promoting the principle of health equity under diverse real-world settings. Full article

Wire and cable are important industrial products involving the national economy and people’s livelihood, which are hailed as the “blood vessel” and “nerve” of the national economy, providing the basic guarantee for the normal operation of modern economy and society. The data traceability of their production and circulation process is a key factor in ensuring their quality and safety management. We aim to solve the problems of unsafe data transmission, weak quality control, and information islands in the process of wire and cable quality traceability in order to improve the production management efficiency of wire and cable manufacturing enterprises and to reduce the cost of consumer quality traceability of wire and cable products. We analyzed the technical characteristics and advantages of Industrial Internet of Things (IIoT) identity resolution and the blockchain. Key technologies are introduced, a traceability method that integrates the two is proposed, and a quality traceability framework based on the IIoT identity resolution system and blockchain technology is constructed. By analyzing the quality information composition of the wire and cable supply chain, a new quality traceability model based on the wire and cable supply chain is established. Finally, through the verification of the developed quality traceability system, the quality traceability function and quality information of each production link of wire and cable are successfully realized. This paper fills a gap in the field of cable product quality traceability using the combination of IIoT and blockchain technology. According to this model, it also has some potential for the traceability of other industrial products. Full article

Eggs represent one of the most consumed animal products worldwide. In Europe, over 366 million laying hens and 6.1 Mt of derived eggs have been estimated in 2020, and Italy represents the fourth largest producer (41 million hens and 0.79 Mt of eggs). Egg production has been identified as relatively environmental-friendly, but several environmental concerns have been recently raised considering the inefficient spent hens’ management. Spent hens are generally euthanized and composted or incinerated, producing greenhouse gases while at the same time significant nutrients are lost. First, the research reviews the egg supply chain characteristics and the alternative spent hens’ valorization pathways. Then, using the material flow analysis, the research quantifies and qualifies the consistencies of laying hens and protein content included in spent hens across Italy, providing a comprehensive assessment of the national scenario under an environmental and circular perspective. Furthermore, the research develops an inventory of the spent hens’ co-products and by-products in Italy, focusing on the flows of proteins for further environmental studies. The research has highlighted that over 13,948 t of proteins could be extracted, distinguishing between those embedded within offal, feathers and blood. In addition, spent hens can be used for human consumption, as well as for material or energy recovery through anaerobic digestion or microbial fermentation. Results are addressed to farmers, who are required to boost their environmental performances, and public authorities, who must implement sustainable strategies to collect spent hens. Full article

The blood supply chain is an inseparable part of health systems. The importance of blood and the difficulties of managing the blood supply chain have led to numerous publications on this topic over the last two decades. This study seeks to reveal the state of the art of the blood supply chain and provide research gaps and future research directions. For this purpose, a mixed review methodology is conducted that includes bibliometric analysis, network analysis, and a six-dimension taxonomy. Bibliometric analysis identifies the most contributing journals, authors, and countries as well as provides popular keywords, while network analysis reveals interactions between these components. Taxonomy clarifies decision models and research gaps with a deeper examination. The electronic database Web of Science is examined to uncover relevant articles. In total, 265 articles are analyzed in detail. The findings reveal that the blood supply chain gathers more interest from researchers, and despite the continuing dominance of the inventory stage, there is an upward trend in the literature for the research of the blood supply chain as a whole. Optimization techniques come forward in the blood supply chain topic as solution methodology. In accordance with the results of bibliometric analysis, network analysis, and taxonomy, six prospective directions for future research are emphasized. Full article

Blood platelets are a typical instance of perishable age-differentiated products with a shelf life of five days (on average), which may lead to significant wastage of some collected samples. At the same time, a shortage of platelets may also be observed because of emergency demands and the limited number of donors, especially during disasters such as wars and the COVID-19 pandemic. Therefore, developing an efficient blood platelet supply chain management model is highly necessary to reduce shortage and wastage. In this research, an integrated resilient–sustainable supply chain network of perishable age-differentiated platelets considering vertical and horizontal transshipment is designed. In order to achieve sustainability, economic cost, social cost (shortage), and environmental cost (wastage) are taken into account. A reactive resilient strategy utilizing lateral transshipment between hospitals is adopted to make the blood platelet supply chain powerful against shortage and disruption risks. The presented model is solved using a metaheuristic based on a local search-empowered grey wolf optimizer. The obtained results demonstrate the efficiency of the proposed vertical–horizontal transshipment model in reducing total economic cost, shortage, and wastage by 3.61%, 30.1%, and 18.8%, respectively. Full article

The management and supply of blood are critical yet considered a challenging exercise within the healthcare industry. The inventory managers within the sector concerned with blood storage and transportation always focus on their consumers’ effective and timely responses. A lack of blood during emergencies significantly impacts patients’ lives needing a blood transfusion. On the other hand, blood transfusion to needy patients must be effective and timely, requiring adequate transportation and supply chain policies. A weak transportation system could lead to blood shortages, delivery inefficiencies, and even contamination during the process. There are few blood donors globally; therefore, any wastage due to a poor delivery solution is ineffective. The current review aims to offer a comparative study of blood delivery within crowded cities, specifically using cars and motorcycles as the leading delivery solutions. Based on the systematic literature review, the most effective and responsive blood delivery system in a congested city may be identified considering SC costs, time availability, and emergency severity. The present research provides a comparative analysis of the available blood delivery systems in a congested city. It also helps the stakeholders to take quick and responsive decisions quickly. Full article

Despite the efforts of the World Health Organization, blood transfusions and delivery are still the crucial challenges in blood supply chain management, especially when there is a high demand and not enough blood inventory. Consequently, reducing uncertainty in blood demand, waste, and shortages has become a primary goal. In this paper, we propose a smart platform-oriented approach that will create a robust blood demand and supply chain able to achieve the goals of reducing uncertainty in blood demand by forecasting blood collection/demand, and reducing blood wastage and shortage by balancing blood collection and distribution based on an effective blood inventory management. We use machine learning and time series forecasting models to develop an AI/ML decision support system. It is an effective tool with three main modules that directly and indirectly impact all phases of the blood supply chain: (i) the blood demand forecasting module is designed to forecast blood demand; (ii) blood donor classification helps predict daily unbooked donors thereby enhancing the ability to control the volume of blood collected based on the results of blood demand forecasting; and (iii) scheduling blood donation appointments according to the expected number and type of blood donations, thus improving the quantity of blood by reducing the number of canceled appointments, and indirectly improving the quality and quantity of blood supply by decreasing the number of unqualified donors, thereby reducing the amount of invalid blood after and before preparation. As a result of the system’s improvements, blood shortages and waste can be reduced. The proposed solution provides robust and accurate predictions and identifies important clinical predictors for blood demand forecasting. Compared with the past year’s historical data, our integrated proposed system increased collected blood volume by 11%, decreased inventory wastage by 20%, and had a low incidence of shortages. Full article

A supply chain (SC) is a network of interests, information, and materials involved in processes that produce value for customers. The implementation of blockchain technology in SC management in healthcare has had results. This review aims to summarize how blockchain technology has been used to address SC challenges in healthcare, specifically for drugs, medical devices (DMDs), and blood, organs, and tissues (BOTs). A systematic review was conducted by following the PRISMA guidelines and searching the PubMed and Proquest databases. English-language studies were included, while non-primary studies, as well as surveys, were excluded. After full-text assessment, 28 articles met the criteria for inclusion. Of these, 15 (54%) were classified as simulation studies, 12 (43%) were classified as theoretical, and only one was classified as a real case study. Most of the articles (n = 23, 82%) included the adoption of smart contracts. The findings of this systematic review indicated a significant but immature interest in the topic, with diverse ideas and methodologies, but without effective real-life applications. Full article

COVID-19 is recognized as an infectious disease generated by serious acute respiratory syndrome coronavirus 2. COVID-19 has rapidly spread all over the world within a short time period. Due to the coronavirus pandemic transmitting quickly worldwide, the impact on global healthcare systems and healthcare supply chain management has been profound. The COVID-19 outbreak has seriously influenced the routine and daily operations of healthcare facilities and the entire healthcare supply chain management and has brough about a public health crisis. As making sure the availability of healthcare facilities during COVID-19 is crucial, the debate on how to take resilience actions for sustaining healthcare supply chain management has gained new momentum. Apart from the logistics of handling human remains in some countries, supplies within the communities are urgently needed for emergency response. This study focuses on a comprehensive evaluation of the current practices of healthcare supply chain management in Hong Kong and the United States under COVID-19 settings. A wide range of different aspects associated with healthcare supply chain operations are considered, including the best practices for using respirators, transport of life-saving medical supplies, contingency healthcare strategies, blood distribution, and best practices for using disinfectants, as well as human remains handling and logistics. The outcomes of the conducted research identify the existing healthcare supply chain trends in two major Eastern and Western regions of the world, Hong Kong and the United States, and determine the key challenges and propose some strategies that can improve the effectiveness of healthcare supply chain management under COVID-19 settings. The study highlights how to build resilient healthcare supply chain management preparedness for future emergencies. Full article

Background: This research aims to prioritize the blood supply hub for coping barriers of implementation blockchain (BC) in supply chain management (SCM). Nowadays, blood supply is a crucial matter that plays an essential role in people’s lives. Hence, tracing the supply of blood is very substantial. One of the ways for the SCM of blood supply is a blockchain system. It shows how all traces of the SCM stream can flow from raw material to receiving blood into end users. However, there are many barriers to the implementation of blockchain. None of the companies can design improvement projects to resolve these barriers because of a lack of rare resources, such as human resources (HR), budget, information, etc. Methods: Barriers are first extracted from previous studies and interviews with experts in this study. Then, these barriers are customized for this case study by the Delphi method. Then, these blood supply hubs are ranked by measurement alternatives and ranking according to the compromise solution (MARCOS) method. Since this method needs primary weight, the best–worst method (BWM) is applied to obtain this weight. Result: Results have pointed out that business owners’ unwillingness was the highest priority among the nine barriers. Conclusions: Additionally, implementing blockchain for SCM of blood supply requires paying more attention to business owners’ unwillingness barriers and resolving them. Furthermore, hub 4 is faced with many problems in tackling barriers to implementing SCM blockchain. Full article

Health systems are recognised as playing a potentially important role in many risk management strategies; however, there is strong evidence that health systems themselves have been the victims of unanticipated risks and have lost their functionality in providing reliable services. Existing risk identification and assessment tools in the health sector, particularly in the blood supply chain, address and evaluate risks without taking into account their interdependence and a holistic perspective. As a result, the aim of this paper is to develop a new systemic framework based on a semi-quantitative risk assessment approach to measure supply chain risks, which will be implemented through a case study on the Iranian BSC. This paper identifies and assesses supply chain risks (SCRs) by employing a novel systemic process known as SSM-SNA-ISM (SSI). First, the supply chain and its risks are identified using Soft Systems Methodology (SSM). Then, given the large number of risks, the second stage uses Social Network Analysis (SNA) to identify the relationships between the risks and select the most important ones. In the third stage, risk levelling is performed with a more in-depth analysis of the selected risks and the application of Interpretive Structural Modelling (ISM), and further analysis is performed using the Cross-Impact Matrix Multiplication Applied to Classification (MICMAC). The study found that by using the new proposed approach, taking into account risk relationships, and taking a holistic view, various supply chain risks could be assessed more effectively, especially when the number of risks is large. The findings also revealed that resolving the root risks of the blood supply chain frequently necessitates management skills. This paper contributes to the literature on supply chain risk management in two ways: First, a novel systemic approach to identifying and evaluating risks is proposed. This process offers a fresh perspective on supply chain risk modelling by utilising systems thinking tools. Second, by identifying Iranian BSC risks and identifying special risks. Full article

Due to the rapid change of population structure, leading to lower birth rates and quick aging rates, the demand for blood supply is increasing significantly. In most countries, blood quality and origin are managed by blood management information systems, such as national authorities. Nevertheless, the traditional system has limitations in this field, such as a lack of detailed blood information, making it challenging to manage blood quality, supply, and demand. Hence, to solve these issues, this paper proposes a blockchain-based system called BloodChain, an improved system to support blood information management, providing more detailed information about blood, such as blood consumption and disposal. BloodChain exploits private blockchain techniques with a limited number of relatively fast and reliable participants, making them suitable for B2B (Business to Business) transactions. In this paper, we also develop a proposed system based on the architecture of Hyperledger Fabric. The evaluation of BloodChain is performed in several scenarios to prove our proposed model’s effectiveness. Full article

(1) Background: The COVID-19 pandemic tested the public health system’s readiness for crises and highlighted the importance of knowing the demand for blood products and the maintenance of the blood supply chain. The aim of this study was to evaluate blood product usage in a series of patients that were hospitalized due to COVID-19 and to analyze their demographics and clinical characteristics. (2) Methods: In this retrospective cohort study, we analyzed data from transfused COVID-19 patients that were treated in the University Hospital Medical Center Bezanijska Kosa in Belgrade, Serbia during the second wave of the epidemic. (3) Results: This study included 90 patients. The median age of the patients was 72 (range 23–95) years. The median time of hospitalization was 23 days (range 3–73 days). In intensive care units (ICUs) the median time of hospitalization was 9 days (range 0–73). One or more comorbidities were observed in 86 individuals (95.6%). The total number of transfused red blood cell concetrates (RBC) was 304 (139 in ICU, 165 in other wards), with a mean of 3 units/patient (range 1–14). Comorbidities, severity of illness and hospital duration in the ICU were statistically significant predictors of higher RBC use. (4) Conclusion: Knowledge of the transfusion profile of COVID-19 patients allowed better management of the hospital’s blood stocks during the COVID-19 pandemic. Full article